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Nijmegen breakage syndrome (NBS) results from
the absence of the NBS1 protein, responsible for
detection of DNA double-strand breaks (DSBs).
NBS is characterized by microcephaly, growth retar-
dation, immunodeficiency, and cancer predisposi-
tion. Here, we show successful reprogramming
of NBS fibroblasts into induced pluripotent stem
cells (NBS-iPSCs). Our data suggest a strong selec-
tion for karyotypically normal fibroblasts to go
through the reprogramming process. NBS-iPSCs
then acquire numerous chromosomal aberrations
and show a delayed response to DSB induction.
Furthermore, NBS-iPSCs display slower growth,
mitotic inhibition, a reduced apoptotic response
to stress, and abnormal cell-cycle-related gene
expression. Importantly, NBS neural progenitor cells
(NBS-NPCs) show downregulation of neural devel-
opmental genes, which seems to be mediated by
P53. Our results demonstrate the importance of
NBS1 in early human development, shed light on
the molecular mechanisms underlying this severe
syndrome, and further expand our knowledge of
the genomic stress cells experience during the
reprogramming process.INTRODUCTION
Nijmegen breakage syndrome (NBS) is a rare autosomal
recessive disease that results from a null mutation in the
NBS1 gene (Carney et al., 1998; Varon et al., 1998). NBS1
together with MRE11 and RAD50, form the MRN complex
that senses DNA double-strand breaks (DSBs) and starts the
DNA repair cascade (Carney et al., 1998). Due to the critical
role of NBS1 in the cellular DNA damage response (DDR),Cell Re
This is an open access article under the CC BY-Naffected children with the disease have an exceptionally high
risk of developing cancer at a young age (van der Burgt
et al., 1996). This is accompanied with other cardinal pheno-
types of the syndrome such as progressive microcephaly
with distinct facial features, growth delay, immunodeficiency,
and premature ovarian failure in girls. Neurocognitive abilities
vary among patients but mental retardation usually progresses
during childhood (Chrzanowska et al., 2012; van der Burgt
et al., 1996).
Previous work on cells derived from NBS patients suggested
impairments in cell cycle and regulation of apoptosis (Buscemi
et al., 2001; Hou et al., 2012; Jongmans et al., 1997; Porcedda
et al., 2006; Rogoff et al., 2004). Moreover, NBS1 was shown
to modulate cellular P53 levels through kinase activation (Jong-
mans et al., 1997; Lee and Paull, 2005). In the past, murine
models were created to study NBS; however, null mutations of
NBS1 in mice resulted in early embryonic lethality (Zhu et al.,
2001). A mouse model with a truncated NBS1 protein was also
created; this model also failed to recapitulate the phenotypes
seen in humans, as it showed no immunodeficiency and no
increased in cancer development, and the animals were fertile
(Williams et al., 2002). In order to study the importance of
NBS1 in early development and the features of the disease
that lead to the severe phenotypes seen in affected individuals,
a different model system must be used. Human embryonic
stem cells (ESCs) serve as a great tool in modeling develop-
mental diseases. However, due to the rarity of the syndrome,
we do not know of any ESCs with NBS available for research.
To overcome this obstacle, we utilized primary NBS fibroblasts
that can be reprogrammed into induced pluripotent stem cells
(iPSCs) and thus be used to model NBS or other syndromes
caused by aberrant DDR. Reprogramming of somatic cells into
pluripotent cells has become a routine procedure in many labs;
however, some studies have suggested that lack of different
DDR proteins renders this process inefficient (Nayler et al.,
2012; Raya et al., 2009; Tilgner et al., 2013; Yung et al., 2013).
Moreover, the reprogramming process coupled with a DDR
mutation and prolonged culturing induces stress to the genomic
integrity of these cells and so must be closely monitored.ports 16, 2499–2511, August 30, 2016 ª 2016 The Author(s). 2499
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. NBS-iPSCs Characterization
NBS fibroblasts from patient A were reprogrammed to iPSCs and analyzed at cellular and molecular levels.
(A) Colony morphology analysis showed compact and round monolayer colonies with a high nucleus to cytoplasm ration.
(B) NBS colonies stained positive for alkaline phosphatase activity.
(C) Immunohistochemistry staining showed positive staining for TRA-1-60 and OCT4.
(D) Expression levels of pluripotency genes were analyzed by microarray and showed similar expression levels between WT and NBS-derived iPSCs (each
column represents the average value of two microarrays, bars mark SE).
(legend continued on next page)
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In this study, we show successful reprogramming of NBS
fibroblasts into pluripotent stem cells (NBS-iPSCs). We suggest
that mainly fibroblasts with normal karyotype are able to com-
plete the reprogramming process, and through this process
they acquire new sporadic abnormalities. We further demon-
strate abnormal response to DSBs, the most deleterious type
of DNA damage. In addition, NBS-iPSCs display differential
expression of cell-cycle genes compared with wild-type (WT)-
iPSCs, accumulation in G2/M, and reduced apoptosis in
response to stress. Differentiation of NBS-iPSCs into neural
progenitor cells (NBS-NPCs) revealed abnormalities in neural
developmental genes, apparently due to NBS-NPCs inability to
maintain normal levels of P53.
The data presented in this work emphasize the importance of
NBS1 and proper DNA damage recognition in early development
to the stem cell pool and nervous system. It further demonstrates
the different cellular and molecular pathways most susceptible
to deficits in NBS1 and shows the genomic stress and selective
forces that cells experience during the processes of reprogram-
ming and expansion in culture.
RESULTS
Generation and Characterization of NBS-Derived-
Induced Pluripotent Stem Cells
Very little is known about the DDR in stem cells and early devel-
opment. To understand the importance of DDR in pluripotent
cells, we chose to study NBS, as this syndrome results from
the absence of the NBS1 protein, which senses DSBs and is at
the apex of the DDR cascade. In order to create a model system,
we utilized primary fibroblasts of a female patient (patient A)
homozygous for the NBS1 657del5 founder mutation, which
appears in more than 90% of NBS patients (Antoccia et al.,
2006). We have previously established NBS-derived iPSCs
(NBS-iPSCs) from a male NBS patient, also carrying the 5-bp
founder deletion (Mlody and Adjaye, 2015) (clones 1 and 2
from patient B). For this study, we established six new NBS-
iPSC clones named clones 4, 26, 31, 33, 34, and 36 from patient
A, by reprogramming of the primary fibroblasts based on the
Yamanaka’s reprogramming protocol (Takahashi et al., 2007).
During the reprogramming process, we did not observe any
significant difference in the efficiency of colony formation be-
tween NBS and WT cells. All clones showed typical stem cell
morphology with a defined round colony growth and large nu-
cleus to cytoplasm ratio (Figure 1A). All NBS-iPSC clones stained
positive for pluripotent markers such as alkaline phosphatase
activity (Figure 1B), nuclear expression of OCT4, and cell-surface
expression of TRA-1-60 (Figure 1C). Next, DNA microarray anal-(E) Sequencing of exon 6 of the NBS1 gene shows 5-bp ACAAA founder deletio
(F) The presence of the NBS1 protein was analyzed using western blot analysis. T
NBS-derived fibroblasts or iPSCs.
(G) Embryoid bodies were formed from NBS-iPSCs and grown for 20 days in cul
quantitative real-time PCR. Results show expression of genes representing the d
(H) WT- and NBS-iPSC colonies were analyzed for growth rate. NBS-iPSCs sho
For (A)–(C) and (E), all six clones were analyzed (figure showing results for either
and (H) clones 26, 34, and 36 were analyzed. For (G) and (H), three biological re
Student’s t test.ysis was performed and showed expression of pluripotent genes
such as SOX2, OCT3/4, NANOG, and REX1 at similar levels to
iPSCs derived from healthy individuals (WT iPSCs) (Figure 1D).
To verify that the newly derived NBS-iPSCs still carry the 5-bp
deletion founder mutation, we sequenced exon 6 of the NBS1
gene and compared with our control cells. Sequencing results
show that NBS-iPSCs still carry the 5-bp deletion that was char-
acterized in the fibroblasts of origin (Figure 1E). NBS1 protein
levels were also analyzed in both the patient’s fibroblasts and
in the derived iPSCs to confirm lack of expression. Western
blot analysis clearly shows that neither fibroblasts nor iPSCs
derived from the NBS patient A contain any detectable NBS1
protein in contrast to WT fibroblasts and iPSCs (Figure 1F).
The pluripotency of the NBS-iPSCs was also analyzed by the
formation of embryoid bodies (EBs) and spontaneous differenti-
ation into the three germ layers. Quantitative real-time PCR anal-
ysis of RNA isolated from 20-day-old NBS-derived EBs shows
expression of a-fetal protein (AFP), a marker for endoderm for-
mation, of Chordin (CHRD), a marker for mesoderm formation,
and of PAX6, an early marker for ectoderm formation (Figure 1G).
While culturing the NBS-iPSCs, we noticed a much slower
growth rate between passaging compared with all other iPSC
lines grown in the lab. To quantify and verify this phenomenon,
we employed a growth assay analysis. The analysis showed a
significantly slower growth rate for NBS clones compared with
WT-iPSCs (Figure 1H).
Karyotype Analysis of NBS-iPSCs Exhibits Numerous De
Novo Aberrations
Karyotype analysis is performed for every newly generated iPSC
clone in order to ensure the absence of major aberrations. This is
especially important in lines derived from cells mutated in genes
involved in the cellular response to DNA damage. Our karyotype
analysis of NBS-iPSC clones at early passaging after reprogram-
ming revealed numerous aberrations, such as gain of chromo-
somes, deletions, and breaks, in almost all clones analyzed
(Figure 2A; Table 1). To understand the severity and scope of
the aberrations, we compared NBS-iPSCmetaphaseswith other
normal or disease-derived iPSCs and with healthy ESCs, at very
early passages. Of the 318 ESCs metaphases analyzed in total,
only 13 metaphases exhibited missing chromosomes. Missing
chromosomes, however, are mostly the result of the preparation
process for metaphase analysis. As the cells are spread to
release the chromosomes, some may spread too far and out of
the field being analyzed. Nevertheless, the missing metaphases
amount to 4% of all metaphases analyzed (Table 1). Strikingly,
the same was true when analyzing iPSCs derived from healthy
individuals or from patients with a syndrome unrelated to then in NBS-iPSCs but not in WT-iPSCs.
he NBS1 antibody was able to detect the presence of NBS1 in WT- but not in
ture. Spontaneous differentiation for the three germ layers was analyzed using
ifferent embryonic germ layers.
w markedly slower growth rate over time compared with WT-iPSCs.
34 and 36 or both). For (D) and (F), clones 34 and 36 were analyzed and for (G)
peats were analyzed; scale bars represent SE, *p < 0.005, **p < 0.0005, using
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Figure 2. Karyotype Analysis of NBS Cells
Reveals Genomic Instability
(A) Karyotype analysis of metaphase spreads
displays chromosomal aberrations such as breaks
and deletions in NBS-iPSCs.
(B) Even more severe aberrations such as trans-
locations are found in the NBS fibroblasts of origin;
for both metaphases, red arrows mark aberra-
tions.
(C) Analysis of all aberrations in early-passage
NBS-iPSCs shows numerous spontaneous de
novo mutations compared with NBS fibroblasts.
(D) Chromosomal ideogram depicts aberration
types; with chromosomes 1, 8, and 9 being
affected the most. Left-side vertical lines repre-
sent deletions, right-side vertical lines represent
duplications and right-side horizontal lines repre-
sent breaks.
(E) Analysis of NBS-iPSC clone 36 shows the
stabilization and domination of a growth advan-
tageous aberration on chromosome 12 over long
culturing (passages [p] 11, 22, and 46 for each
passage, 20, 11, and ten metaphases were
analyzed, respectively).DDR. Out of the 121 iPSC metaphases analyzed, we observed
five metaphases with missing chromosomes, which account
for 4% aberrant metaphases as seen in ESCs (Table 1). When
analyzing the NBS-iPSC metaphases, we observed some varia-
tion between the different clones. Clone 31 lost either the long
arm of chromosome 14 or the entire chromosome completely
in all analyzed metaphases (Table 1). This results in 100% aber-
rant metaphases for this clone. In this case, clone 31 was not
included in the final percentage of aberrant metaphases in
NBS-iPSC clones. It is worth pointing out that this clone had a
high growth rate compared with the other NBS-iPSC clones,
and similar to WT-iPSCs (data not shown). For these reasons,
NBS-iPSC clone 31was not used in other analyses. Other clones
showed different aberrations that were not consistent to all
metaphases. In total, NBS-iPSCs show about 51% aberrant
metaphases with most aberrations not resulting from a missing2502 Cell Reports 16, 2499–2511, August 30, 2016chromosome (Table 1). Due to the fact
that reprogramming is a clonal process
in which an isolated NBS clone had
originated from a single fibroblast and
because most of the aberrations found
in NBS-iPSCs were not recurrent mean-
ing they did not originated in the parent
fibroblast of the analyzed clones, we
wished to understand the impact of the
reprogramming process on the genome
stability of our cells. For this, we per-
formed karyotype analysis on the pa-
tient’s fibroblasts. The analysis revealed
severe genomic instability, resulting in
many aberrations of various kinds. In
fact, 75% of all metaphases were aber-
rant, exhibiting types of aberrations that
were not present in the NBS-iPSCs,such as inversions and translocations (Figures 2B and 2C;
Table 1). The percentage of aberrant metaphases in the NBS fi-
broblasts wasmuch greater than was observed in the NBS-iPSC
and none of the aberrations that were seen in the fibroblasts
were observed in the early passages of the iPSCs (Figure 2C).
To verify whether the aberrations occurred at the induction of
pluripotency by the reprogramming factors or later during the
expansion of the clones, we plotted them by chromosomal posi-
tion and cell type (Figure 2C). It is visible that all aberrations seen
in NBS-iPSCs are different from those seen in NBS fibroblasts.
Moreover, the aberrations seem to be stochastic within each
clone except for clone 31 in which a deletion of the long arm of
chromosome 14 or the entire chromosome occurred in all
analyzed metaphases (Figure 2C). Next, we wished to under-
stand whether there are aberration related ‘‘hot spots’’ or aber-
ration ‘‘resistant’’ or ‘‘prone’’ chromosomes. For this analysis,
Table 1. Aberrations Summary of Different WT and Disease-Derived iPSCs
Cell Line
No. of
Metaphases
Loss of
Chromosome
Gain of
Chromosome Deletions Breaks Inversions Translocations
Total Aberrant
Metaphases (%)
%Loss/
%Other
ESCs 318 13 — — — — — 4 4/0
FXiPSCs 52 20 — — — — — — 0 0/0
GM26iPSCs 20 — — — — — — 0 0/0
PGiPS 20 20 — — — — — — 0 0/0
BJiPSCs 28 20 1 — — — — — 5 5/0
FXiPSCs 12 21 2 — — — — — 9.5 9.5/0
BetaiPSCs 20 2 — — — — — 10 10/0
All iPSCs 121 5 — — — — — 4 4/0
NBS fibroblasts 28 18 4 — 7 1 9 71 64/75
NBS iPSCs 4 20 4 1 2 1 — — 40 30/20
NBS iPSCs 26 22 1 3 — 7 — — 32 10/32
NBS iPSCs 31 10 3 2 7 — — — 100 30/90
NBS iPSCs 33 13 5 — 2 — — — 30 30/15
NBS iPSCs 34 21 5 5 2 2 — — 62 24/43
NBS iPSCs 36 20 3 — 3 4 — — 45 15/35
All NBS iPSCs 106 21 10 14 9 — — 52 23/39
Metaphases of WT-ESCs, fragile X syndrome (FXS)-derived iPSCs (FXiPSCs 52, FXiPSCs 12), female fibroblast-derived iPSCs (GM26iPSCs), tera-
toma-derived iPSCs (PGiPS 20), BJ-derived iPSCs (BJiPSCs), b cell-derived iPSCs (BetaiPSCs), NBS fibroblasts, and NBS-iPSCs (clones 4, 26,
31, 33, 34, and 36) were karyotyped and checked for aberrations. On average, ESCs and iPSCs display 4% missing metaphases and no other aber-
rations. In contrast, NBS fibroblasts and iPSCs display an array of aberrations in significantly higher percentages at early passages (under passage 11).we mapped all the aberrations to correspond with their position
on a chromosomal ideogram. We could see that in NBS-iPSCs,
the larger chromosomes (chromosomes 1–6) were rather poor
in aberrations, except for chromosome 1 in which we observed
a higher frequency of aberrations. In the medium-sized chromo-
somes (chromosomes 7–15), we observed numerous aberra-
tions, especially in chromosome 9. Last, in the smaller chromo-
somes (16–22), there were very few aberrations (Figure 2D).
Finally, we wished to study the long-term effects of the genome
instability of NBS-iPSCs in culture and how it affects the genomic
makeup of the cells. Over a long culturing period, we could
detect the establishment of a chromosomal aberration known
to confer a growth advantage. While in passage 11 (p.11), there
were various single to double metaphase aberrations, most of
them were not present in passage 22 (p.22) with the appearance
of an addition on chromosome 12 aberration and had completely
disappeared by passage 46 (p.46) with a domination of the chro-
mosome 12 addition aberration in all analyzed metaphases
(Figure 2E).
NBS-iPSCs Show a Delayed Response to DSBs with
Incomplete Resolution
After analyzing the cellular properties of the NBS-iPSCs, we
broadened our analysis to the molecular level to better under-
stand the basis for the syndrome. In order to evaluate the cells
response to DSBs, we treated the cells with the radiomimetic
drug phleomycin and let the cells detect and recover the dam-
age for different lengths of time before fixation and staining
against 53BP1, a marker for DSBs. The results display differ-
ences in the response to the induction of DSBs and the distri-
bution of the amount of foci each cell contains in both patients(Figure 3A). Quantification of the average number of foci per
cell shows that, under normal growing conditions without
the induction of DSBs, both WT and NBS-iPSCs have a base-
line average of about two to two and a half foci per cell. How-
ever, after 30 min of recovery following DSB induction, WT
cells show a fast, maximal response with an average of 25
foci per cell, whereas NBS-iPSCs show a slower response,
with an average of 19 foci per cell (Figures 3A and S1A). After
6 hr of recovery following the induction of DSBs, we observed
an augmentation of the difference in the response. While the
WT cells have resolved many of the breaks and reduced the
average number of foci per cell from 25 to 16, only at this
point do the NBS-iPSCs reached maximal response with
almost no DNA damage resolution as the cells contain an
average of 23 foci per cell (Figures 3A and S1A). The same
trend is also seen after 24 hr of recovery following the induc-
tion of DSBs. As the number of foci in WT cells decline to only
five foci per cell, NBS-iPSCs show double the amount of
unresolved breaks with an average of about 11 foci per cell
(Figures 3A and S1A).
When looking at the total number of foci per cell under
normal culturing conditions, without the induction of DSBs,
we see a similar distribution of foci number among WT- and
NBS-iPSCs (Figure 3B). Both WT- and NBS-iPSCs show
that the majority of cells, around 65%, contain between zero
and two foci. About a third of the cells contain between three
and ten foci, and about 5% contain up to 25 foci. No cell was
found to contain more than 25 foci for either cell type (Fig-
ure 3B). When analyzing the cells 24 hr after the induction
of DSBs, we observed a very different distribution of the
number of foci in each cell among WT- and NBS-iPSCs. WhileCell Reports 16, 2499–2511, August 30, 2016 2503
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Figure 3. Aberrant Gene Expression and
Response to DSBs in NBS-iPSCs
(A–C) DSBs were induced in WT- and NBS-iPSCs
with phleomycin. (A) Violin plot showing the dis-
tribution of cells with different numbers of foci for
each cell type at ground state (Control) and at
different time points after recovery from phleo-
mycin. (B) Before the induction of DSBs, both
WT- and NBS-iPSCs display similar distribution
of foci per cell. (C) This distribution is dramatically
changed 24 hr after the induction of DSBs with
higher percentages of NBS-iPSCs displaying
numerous foci in clones from the two NBS patients
(three to four biological repeats, scale bars
represent SE, **p < 0.0001, using Mann-Whitney
U test).
(D and E) Global gene expression of NBS-iPSCs
was analyzed, revealing differences in various
cellular pathways compared with WT-iPSCs.
(D) Microarray analysis shows downregulation of
different cell-cycle genes, among them mitosis-
related genes, and apoptosis-inducing genes in
NBS compared with WT-iPSCs. (E) In contrast,
mitosis- and apoptosis-inhibiting genes were up-
regulated in NBS-iPSCs compared with control
(WT) (each column represents the average value of
two microarrays, bars mark SE).
(F) Quantitative real-time PCR analysis was per-
formed on two mitosis- and one apoptosis-related
genes, showing significant differences between
NBS- and WT-iPSC gene expression.
(G) The same genes were analyzed by quantitative
real-time PCR in NBS and WT fibroblasts and re-
vealed similar expression of mitosis-related genes
but an elevation in the apoptosis-related gene in
NBS fibroblasts (Fibs) comparedwith control (WT).
For (A)–(C), clones 26, 34, and 36 were analyzed
from patient A and clones 1 and 2 from patient B.
For (D) and (E), clones 34 and 36were analyzed; for
(F), clones 26, 33, 34, and 36were analyzed. For (F)
and (G), three biological repeats were analyzed;
scale bars represent SE, *p < 0.05, using Student’s
t test.the WT-iPSCs display percentages very similar to those
observed at the basal levels, NBS-iPSCs still show very high
percentages of cells containing many foci with very few cells
containing no foci at all (Figure 3C). This is most obvious for
the group of cells containing between zero and two foci. In
WT-iPSCs, the zero-to-two-foci category consists of more
than 45% of all cells, while, in NBS-iPSCs, this category
consist of a mere 5% or less of the cells (Figure 3C). 37%
of all WT cells fall in the three-to-ten-foci-per-cell category,
very close to the basal level, while in NBS cells this group con-
sists of more than 50% of the cells. About 14% of WT cells
contain 11–25 foci in contrast to about 36% of NBS cells.
Some cells after 24 hr of recovery still contain more than2504 Cell Reports 16, 2499–2511, August 30, 201625 foci, yet in WT cells they amount to
only about 1% of the cells, while in
NBS cells they make up more than 4%
of all cells. Finally, we can see that
around 1% of all NBS-iPSCs after24 hr of recovery still contain more than 50 foci, which is
not observed at all in WT iPSCs at any time point analyzed
(Figure 3C).
Abnormal Gene Expression, Cell-Cycle, and Apoptotic
Response in NBS-iPSCs
In order to understand the molecular basis underlying the differ-
ences seen between WT- and NBS-iPSCs, we compared total
gene expression profiles using DNAmicroarray data. Only genes
that passed a statistical significance of p value <0.05 and were
up- or downregulated by more than 2-fold in NBS-iPSCs
compared with WT-iPSCs were analyzed. At this cutoff, we
found 440 upregulated genes and 562 downregulated genes in
NBS-iPSCs compared with WT-iPSCs. When analyzing these
genes, it was visible that many of the most significantly differen-
tially expressed genes were related to cancer, cell cycle, and
apoptosis (Figures 3D and 3E). Upon closer examination, we
found that genes that inhibit mitosis or apoptosis are upregu-
lated (such as WEE1 and TSPYL5) (Figure 3D), while genes
that promote apoptosis and mitosis are downregulated (such
as TP53I3 and CDC26) (Figure 3E). Thus, according to the
gene expression profile of NBS-iPSCs, both mitosis and
apoptosis are inhibited in these cells. The aberrant expression
of some of these genes was further validated by quantitative
real-time PCR, which verified these genes to be significantly
differentially expressed in NBS- compared with WT-iPSCs (Fig-
ure 3F). To understand whether the changes we detect in gene
expression is a hallmark of the lack of NBS1, we also analyzed
the original primary fibroblasts sample using quantitative real-
time PCR. Results show that in NBS fibroblasts these genes
are expressed differently than seen in iPSCs (Figure 3G). While
WEE1 and CDC26 expression is not significantly different be-
tween WT and NBS fibroblasts, TP53I3 shows significantly
higher expression levels in NBS fibroblasts compared to control,
contrary of what was observed in iPSCs (Figures 3F and 3G). For
a broader view of the transcriptomic differences that charac-
terize NBS-iPSCs, we analyzed all differentially expressed genes
using the Database for Annotation, Visualization, and Integrated
Discovery (DAVID) Functional Annotation Tool. The analysis of
the downregulated genes in NBS-iPSCs showed that mitochon-
drial gene expression is disturbed, as well as genes associated
with ribonucleoproteins (Figure S1B).
In order to verify the effect of the differentially expressed genes
on the cellular characteristics of NBS-iPSCs, we performed flow
cytometry analyses for cell cycle and apoptosis. Cell-cycle anal-
ysis was performed under normal growing conditions and under
stress conditions, where DSBs were induced using phleomycin.
The analysis revealed that NBS-iPSCs spend more time in the
G2/M phase than WT-iPSCs under normal growing conditions
(Figure 4A). In fact, the percentage of NBS-iPSCs at G2/M at
ground state is similar to what is observed in WT-iPSCs under
stress conditions with the induction of DSBs (Figure 4B). Dra-
matic differences were also observed for both G1 and S phases
(Figure 4A). While in WT-iPSCs, under normal growing condi-
tions, more than 55% of the cells are at the G1 phase, in NBS-
iPSCs the percentage of cells in the G1 is about 44%, again,
similar toWT cells under stress conditions (Figure 4B).Moreover,
stress induction by DSBs does not seem to affect the percentage
of NBS-iPSCs found in the G1 stage (Figure 4B). Cells in the
S phase, however, do exhibit changes following induction
of DSBs, but the initial percentage of dividing cells in the
NBS-iPSC culture is significantly lower than observed inWT cells
even under stress conditions (Figures 4A and 4B).
When analyzing the percentage of apoptotic cells in the culture
both under normal growing conditions and under stress condi-
tions induced by the addition of aphidicolin, an inhibitor of DNA
replication, we observed clear differences in the amount of
apoptotic cells, which was higher in WT-iPSCs (Figure 4C).
Visible differences were also observed in the response to stress,
which again was higher in WT-iPSCs and almost lacking in NBS-
iPSCs (Figure 4C). Quantification of differences of the percent-age of apoptotic cells in WT- and NBS-iPSC cultures under
stress showed markedly lower levels of apoptotic cells in the
NBS-iPSC culture compared with WT cell cultures (Figure 4D).
NBS-NPCs Display a p53-Related Abnormal Nervous
System Development
Last, to better understand the severe neural phenotype seen in
NBS patients, NBS-iPSCs were differentiated into NPCs using
Kim et al.’s direct differentiation protocol (Kim et al., 2010).
Next, microarray analysis was performed on NBS-NPCs to
investigate whether their gene expression profile differs from
WT-NPCs. The analysis revealed similar expression levels of
numerous neural markers, among them are NES, PAX6, and
TUBB3 in NBS-NPCs when compared with WT-NPCs (Fig-
ure S1C). We further analyzed the up- and downregulated genes
in NBS-NPCs compared with WT-NPCs using the STRING data-
base for protein-protein interactions and the DAVID functional
annotation clustering tools to detect pathways and mechanisms
that are dysregulated in NBS cells. 29 genes were downregu-
lated in more than a 3-fold change in NBS-NPCs compared
with WT-NPCs. We could detect enrichment for autonomic ner-
vous system development genes with a p value of 8.7E-10 (Fig-
ure 5A). Several of these downregulated genes where further
analyzed by quantitative real-time PCR showing lower expres-
sion levels in both NBS patients when compared with WT-
NPCs (Figure 5B). When lowering the threshold of differential
expression to 2-fold change, we could detect downregulation
of genes related to neurogenesis, transcription, and develop-
ment and upregulation of genes related to nucleolus and ribo-
some (Figures 5C and S1D). In this threshold, we observed 124
downregulated genes in NBS-NPCs compared with WT-NPCs.
Remarkably, this group of genes was significantly enriched for
P53 target genes with 77 out of the 121 downregulated genes
being potential P53 targets according to the DAVID (Figure 5D).
BecauseNBS1 activates P53 (Lee andPaull, 2005), wewished to
know whether NBS-NPCs show downregulation of P53 target
genes due to a failure in maintaining normal P53 levels. To do
so, we employed western blot analysis to detect P53 levels in
NBS-NPCs. The analysis clearly shows that NBS-NPCs contain
only about half the amount of P53 as compared withWT-NPCs in
both patients (Figure 5E).
DISCUSSION
In this work, we have shown the generation and characterization
of a model for NBS and the importance of NBS1 in maintaining
genomic integrity during reprogramming. The generation of
these DDR impaired iPSCs was done without prior gene correc-
tion. As expected, NBS-iPSCs harbored numerous chromo-
somal aberrations (Figures 2A, 2C, and 2D; Table 1). These,
however, seem to be spontaneous and random, as seen from
the stochastic distribution within each clone and did not stem
from the fibroblasts of origin (Figure 2C). This also points to the
idea that these aberrations arise mostly after the reprogramming
process as we do not see recurrent aberrations in our clones.
Because reprogramming is a clonal process in which a single
fibroblast will give rise to a single colony that would be isolated
to establish a clone, an aberration that occurred in this fibroblastCell Reports 16, 2499–2511, August 30, 2016 2505
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Figure 4. NBS-iPSCs Display Cell-Cycle and Apoptotic Differences
(A) Cell-cycle density plots of FACS analysis of WT- and NBS-iPSCs with and without the induction of DSBs display differential distribution of cells between the
G1, S, and G2/M stages as well as differential response to DSBs induction.
(B) Quantification of cell-cycle analysis shows significant differences between WT- and NBS-iPSCs at normal growing conditions (Ctrl) and after induction of
DSBs (+Phleo) in both NBS patients.
(C) Density plots of apoptosis analysis ofWT- andNBS-iPSCs under normal and stress conditions induced by aphidicolin show clear differences in both the levels
of apoptosis and the response to stress.
(D) Quantification of apoptosis FACS analysis under stress conditions reveals markedly less apoptosis in NBS-iPSCs in both patients.
For (A)–(D), clones 26, 34, and 36 were analyzed from patient A and clones 1 and 2 from patient B. All graphs represent three biological repeats; scale bars
represent SE, *p < 0.05, **p < 0.005, ***p < 0.0005 using Student’s t test.cell would be present in all metaphases of the derived iPSC
clone after reprogramming. The fact that NBS-iPSCs display
different types of aberrations that are not recurrent in all
metaphases within a specific clone, together with the finding
that NBS-iPSCs have more karyotically normal metaphases
compared to NBS fibroblasts implies that only fibroblasts with
normal karyotype are able to undergo the reprogramming pro-
cess. Clone 31 from patient A was the only clone to show a
semi-recurrent aberration in early passaging. This aberration
was not found in NBS fibroblasts; however, we could not rule
out the possibility that it originated already at this stage. Another
possibility is that this aberration occurred at the very early stages2506 Cell Reports 16, 2499–2511, August 30, 2016of reprogramming and through the establishment and expansion
in culture it was rooted within this clone. The hypothesis that only
normal fibroblasts are able to be reprogrammed was also raised
in a different study related to reprogramming of DDR impaired fi-
broblasts (Tilgner et al., 2013). After the cells transition to plurip-
otency and rapid divisions, they acquire de novomutations, from
which only those that confer growth advantage or resistance to
cell death will eventually dominate the culture. This is visible in
our NBS-iPSCs long culturing with the addition on chromosome
12 aberration, which is a known growth advantageous aberration
(Figure 2E) (Ben-David et al., 2014; Mayshar et al., 2010). It is
important to note that NBS-iPSCs were grown in low oxygen
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Figure 5. NBS-NPCs Show Poor Activation of Neural Developmental Genes
(A) DNA microarray analysis show downregulation of genes related to autonomic nervous system development of more than 3-fold in NBS- compared with
WT-NPCs (each column represents the average value of two microarrays; bars, SE).
(B) Downregulation of key developmental genes as verified using quantitative real-time PCR in both NBS patient A and B.
(C) When looking at all downregulated genes with a fold change expression of more than 2-fold in NBS- compared with WT-NPCs using the DAVID functional
annotation clustering tool, we observed enrichment for neurogenesis- and development-related proteins.
(D) Many of the downregulated genes in NBS-NPCs are associated with TP53. The association of different proteins is marked by the connecting lines. Each circle
represent one protein; proteins related to development are marked in red.
(E) Western blot analysis of NBS- and WT-NPCs displays lower levels of P53 in NBS-NPCs in both patients. When quantifying, P53 levels in NBS-NPCs reach
about half of those seen in WT-NPCs (three biological repeats, scale bars represent SE, *p < 0.0005, using Student’s t test).
For (A), (C), and (D), clones 34 and 36 were analyzed; for (B), clones 34 and 36 were analyzed from patient A and clones 1 and 2 from patient B. For (E), clones 26,
34, and 36 were analyzed from patient A and clones 1 and 2 from patient B.levels in preparation for most experiments in order to reduce
oxidative stress, as these cells are particularly sensitive. These
findings have implications on our understanding of the cells’ re-
quirements for genome stability during reprogramming and the
stress these cells experience during this process.
NBS-iPSCs are impaired in their DDR yet do not possessmore
DNA breaks than WT-iPSCs under both normal growing condi-
tions and low oxygen growing conditions. This is important as
high oxygen levels can be deleterious to cells, especially ones
with improper DDR. We have shown that the impairment of
NBS cells is manifested in their delayed response to detect
DSBs and to achieve a state of DSBs resolution (Figures 3A–3C and S1A). This may result from problems in recruiting or acti-
vating downstream effectors proteins that repair the damage,
initiate apoptosis, or activate cell-cycle checkpoints, all of which
have been attributed to the normal functions of NBS1 (Buscemi
et al., 2001; Hou et al., 2012; Jongmans et al., 1997; Porcedda
et al., 2006; Rogoff et al., 2004). Since stem cells are more sen-
sitive to aberrations than somatic cells, upon damage they will
not activate the G1/S checkpoint but rather activate apoptosis
(Aladjem et al., 1998; Madden et al., 2011; Momcilovic et al.,
2009; Nagaria et al., 2013; Qin et al., 2007; Suvorova et al.,
2012). The amount of NBS-iPSCs with numerous unresolved
foci may be caused by a failure to activate apoptosis, as wasCell Reports 16, 2499–2511, August 30, 2016 2507
seen also in our flow cytometry analysis (Figures 4C and 4D) and
reinforced by the low levels of p53 seen in NBS-NPCs (Fig-
ure 5D). Entry into S phase or completion of DNA replication
with unresolved breaks will eventually lead to the accumulation
of aberrations, as we observed in NBS-iPSCs. The accelerated
genomic instability caused by these effects will eventually give
rise to growth advantageous mutations, which in patients may
be the cause for the distinctive cancer predisposition character-
istic of this disease.
The aberrant cell regulation of NBS-iPSCs is further supported
by our microarray and quantitative real-time PCR results. Differ-
entially expressed genes in NBS- compared with WT-iPSCs
have functions in cell cycle or more precisely, in mitosis and
apoptosis (Figures 3D–3G). All of these differentially expressed
genes converge to two pathways: downregulation of mitosis
and inhibition of apoptosis. This again was further supported
by our flow cytometry analyses where NBS-iPSCs showed
significantly higher percentages at the G2/M phase and fewer
cells at the G1 and S phases, both under normal growing condi-
tions and upon DSBs induction when compared with control
cells (Figures 4A and 4B). It is also apparent that NBS-iPSCs un-
der normal growing conditions mirror WT cells that are under
stress after induction of DSBs (Figure 4B). Furthermore, these
differences in gene expression between NBS-iPSCs and the
fibroblasts they originated from suggest that the changes in
gene expression observed between WT- and NBS-iPSCs are
specific to the pluripotent state (Figures 3F and 3G). Our finding
that NBS-iPSCs display abnormal mitochondrial gene regulation
(Figure S1B) is in line with several other studies suggesting mito-
chondrial impairment in cells with a related DDR syndrome (Am-
brose et al., 2007; Eaton et al., 2007; Nayler et al., 2012; Shiloh
and Ziv, 2013; Valentin-Vega et al., 2012). A hallmark of mito-
chondrial dysfunction is neurological impairment, and so mito-
chondrial dysregulation may add to the severe neurological
phenotype seen in NBS patients. A recent paper by Larsen
et al. demonstrated the involvement of NBS1 in the silencing
of ribosomal RNA transcription in response to DNA damage
(Larsen et al., 2014). Our study also provides data of RNA pro-
cessing and ribonucleoprotein dysregulation in NBS-iPSCs.
This emerging role of NBS1 in regulation of ribosomal RNA-
related transcription may have many consequences on cell
fate. Bothmitochondrial changes and changes to ribonucleopro-
teins should be further investigated for their role in the cellular
response to DNA damage, in NBS, and in related syndromes
with cancer predisposition or neurological deficits.
To better address the neurological phenotype observed in
NBS patients, we utilized our NBS-iPSCmodel to try and answer
how the lack of NBS1 affects the developing nervous system
of the embryo so severely. By differentiating NBS-iPSCs into
NPCs, we could detect abnormalities in activation of neurogenic
developmental genes (Figures 5A–5C). Some of these genes
are early nervous system developmental genes like TFAP2A,
TFAP2B, HOXB1, and HOXB2, important for neural crest differ-
entiation and regulation of apoptosis (Figure 5B). This phenom-
ena of aberrant regulation of early nervous system development
may stem from the low levels of P53 resulting from the lack of
NBS1, as our analysis revealed that the majority of downregu-
lated genes in NBS-iPSCs are putative targets of P53 (Figures2508 Cell Reports 16, 2499–2511, August 30, 20165D and 5E). In fact, poor maintenance of P53 levels in developing
cells may be responsible for different phenotypes of the syn-
drome. First, due to low levels of P53, cells harboring damaged
DNA will continue to divide, as the cells continue the S phase
with unresolved damage, acquiring more instability that may
lead to cancer (Lane, 1992). Second, among the various roles
of P53, it is also thought to be an important factor in regulating
normal brain development through regulation of NPCs self
renewal and differentiation (Mendrysa et al., 2011; Quadrato
and Di Giovanni, 2012). Several studies have now shown that
even low levels of P53 may lead to aberrant closure of the neural
tube causing several neural malformations (Armstrong et al.,
1995; Isoe et al., 2012; Kawamata and Ochiya, 2012; Mendrysa
et al., 2011; Quadrato and Di Giovanni, 2012; Regeling et al.,
2011; Rinon et al., 2011; Sah et al., 1995). The low levels of
P53 observed in NBS-NPCsmight be the cause for neural abnor-
malities, a prominent feature of NBS. Impairment of DDR activa-
tion and P53 stabilization were previously described in cells
isolated from NBS patients (Buscemi et al., 2001; Hou et al.,
2012; Jongmans et al., 1997; Rogoff et al., 2004). We have
also seen significantly low levels of P53 in our NBS-iPSCs
(data not shown). The P53-related changes we observe in
gene expression in NBS-NPCs but not NBS-iPSCs, although
both show lower levels thanWT cells, might stem from the differ-
ential need in P53 in those cells. Our gene expression analysis of
NBS-iPSCs was done without the induction of stress, and, so,
the lack of P53 may not show a significant impact on global
gene expression, although we do see changes in genes related
to cell cycle and apoptosis. Nevertheless, upon stress or activa-
tion of a cellular program requiring P53, we would expect to
observe a dramatic change in gene expression when compared
with WT cells. This molecular phenotype of P53 necessity to
various cellular pathways may be the basis for the differential
gene regulation by P53 observed when differentiating NBS-
iPSCs into NPCs. These data suggest that P53 deficiency is a
hallmark of NBS cells; however, further work is needed in order
to solidify the relationship between P53, NBS1, and molecular
changes observed in NBS-NPCs. It is plausible that during differ-
entiation each cell type would be affected differently by P53
deficiency and will contribute to a distinct aspect of the disease
depending on the P53 pathways more critical for its functions.
In this work, we present a model for the study of NBS that may
illuminate other DDR syndromes that share the same phenotypic
characteristics. Due to the rarity of NBS, we have utilized previ-
ously generated NBS-iPSCs from a different patient carrying the
same founder mutation (Mlody and Adjaye, 2015). These cells
were characterized for pluripotency alone. Using these and our
newly generated cells, we aimed at characterizing the cells’ mo-
lecular and cellular phenotypes as well as their differentiation
ability and neural phenotype. Our data imply that NBS-iPSCs
undergo fewer divisions producing a smaller stem cell pool.
This is coupled with improper activation of the DDR upon dam-
age, producing genetically unstable cells that remain a part of
this pool instead of activating cell-cycle checkpoints or undergo-
ing apoptosis. Upon differentiation into NPCs, NBS cells also fail
to activate neural developmental genes in correlation with low
levels of P53. All of these cellular and molecular abnormalities
may explain the organs growth failure manifested as dwarfism,
lead to the cancer predisposition and to the neurological deficits,
all of which are hallmarks of NBS patients. These immerging re-
sults linking NBS1, P53, and the neural phenotype observed in
NBS should be further explored in the context of this syndrome
and equally important in other DDR-related syndromes. The
analysis of DDR-deficient cells gives us an insight into the selec-
tion processes during reprogramming and can teach us about
the plasticity and DNA damage defense mechanisms that are
vital at this stage of rapid expansion and commitment to
differentiation.
EXPERIMENTAL PROCEDURES
Cell Culture
NBS primary fibroblasts GM07166 cell lines were purchased from the Cor-
iell Institute and cultured in Minimum Essential Medium (Sigma M5650)
medium supplemented with 15% fetal calf serum (FCS), 2 mM L-glutamine,
50 units/ml penicillin, and 50 mg/ml streptomycin. WT iPSCs were previously
described (Urbach et al., 2010). iPSC cultures were grown in human embryonic
stem cell (HESC) medium containing knockout DMEM (Gibco) supplemented
with 15% Knockout Serum Replacement (Gibco), 2 mM L-glutamine, 0.1 mM
nonessential amino acids, 0.1 mM b-mercaptoethanol, and 4 ng/ml basic
fibroblast growth factor (bFGF) (Cytolab). All cells were maintained in a humid-
ified incubator at 37C and 5% CO2, NBS-iPSCs were grown in either 21%
(standard) or 5% oxygen levels. For embryoid body formation, a 10-cm plate
of medium-sized NBS-iPSC colonies was harvested using trypsin, and cell
clumps were resuspended in HESC medium without bFGF, allowed to aggre-
gate, and transferred to a non-adhesive 10-cm plate (Greiner). Embryoid
bodies were grown for 20 days before harvested for RNA. NPCs differentiation
was carried according to Kim et al.’s Directed Neural Differentiation protocol
with Dorsomorphin (Tocris Bioscience) and SB431542 (Cayman Chemical)
(Kim et al., 2010). NPCs were then fluorescence-activated cell sorted for
NCAM1 positive cells with NCAM1 antibody (R&D Systems).
Generation of NBS-Induced Pluripotent Stem Cells
NBS-iPSCs from patient A were generated as follows. For production of
viral particles, 293T cells were transfected using Fugene 6 (Roche) with
4.5 mg of pMXs retroviral vectors containing human OCT4, SOX2, KLF4, or
c-MYC and 4.5 mg of PCL-Ampho plasmid. At 24 hr after transfection, the
culture was replaced with fresh medium, and, 48 hr after transfection, the su-
pernatant was collected, filtered through a 0.45-mM cellulose acetate filter
(Whatman), and supplemented with 4 mg/ml of Polybrene (Sigma-Aldrich).
600,000 fibroblast cells were infected with viral particles encoding the four fac-
tors. 4 days after infection, the cells were exposed to HESC medium growing
conditions, supported by mitomycin-C-treated mouse embryonic feeder cells.
Morphological changes began to occur approximately 8 days after infection.
Colonies with embryonic stem cell-like morphology were manually expanded.
NBS-iPSCs from patient B were previously described (Mlody and Adjaye,
2015).
Alkaline Phosphatase Staining and Immunocytochemistry
Alkaline phosphatase staining was performed according to the Leukocyte
Alkaline Phosphatase kit protocol (Sigma-Aldrich). For immunocytochemistry
staining, cells were fixed with PBS containing 4% (w/v) formaldehyde for
10 min at room temperature. Cells were washed with PBS containing calcium
and magnesium supplemented with 1% (w/v) FCS and 0.1% (w/v) tween;
the cells were then blocked for 15 min with PBS containing 5% (w/v) FCS,
0.1% (v/v) Triton X-100 (Sigma) and 0.1% (w/v) tween. Fixed cells were incu-
bated overnight with primary antibodies (diluted in blocking buffer as indi-
cated). Primary antibodies were diluted as following: OCT4 (1:100, Santa
Cruz Biotechnology), TRA-1-60 (1:250, Santa Cruz), and 53BP1 (1:250, Bethyl
Laboratories). Secondary antibodies used were cyanine 3 (Cy3)-conjugated
rabbit anti-mouse immunoglobulin (Ig) M or rabbit anti-mouse IgG (1:200,
Jackson ImmunoResearch Laboratories) following staining with Hoechst
33342 (Invitrogen) to detect the cell’s nucleus.RNA Isolation and Reverse Transcription
RNA (DNase treated) was purified using PerfectPure RNA Cultured Cell Kit
(5 PRIME). One microgram of total RNA was used for reverse transcription re-
action using ImProm-II reverse transcriptase (Promega). Quantitative real-time
PCR was performed with 1 mg of RNA reverse transcribed to cDNA, along with
TaqMan Universal Master Mix or SYBR Green qPCR Supermix (see primer list
below; Applied Biosystems) and was analyzed with the 7300 real-time PCR
system (Applied Biosystems).
DNA Microarray Analysis and Functional Annotations Search
RNA was extracted according to the manufacturer’s protocol (Affymetrix).
RNA was subjected to Human Gene 1.0 ST microarray platform (Affymetrix)
analysis; washing and scanning were performed according to the manufac-
turer’s protocol. Arrays were analyzed using Robust Multichip Analysis
(RMA) in the Affymetrix Expression Console. Functional annotations and motif
search were achieved by subjecting differentially expressed genes to the
Database for Annotation, Visualization, and Integrated Discovery (DAVID)
Functional Annotation Tool (http://david.abcc.ncifcrf.gov/) and the STRING
database for protein-protein interactions (http://string-db.org/).
Western Blot Analysis
10% polyacrylamide gel was used for protein separation. The gel was trans-
ferred to a nitrocellulose membrane, and antibody hybridization and chemilu-
minescence were performed according to the standard procedures. The
primary antibodies used in this analysis were rabbit anti-p95NBS1 (Ab-1;
Oncogene Research Products), mouse anti-a-tubulin (Sigma-Aldrich), mouse
anti-p53 (Clone DO-1; Sigma-Aldrich), and rabbit anti-GAPDH (14C10;
Cell Signaling Technology). Horseradish peroxidase (HRP)-conjugated anti-
rabbit and anti-mouse secondary antibodies were obtained from Jackson
ImmunoResearch Laboratories.
Karyotyping
The night before the procedure, hESC culture medium was replaced.
KaryoMAX colcemid (Invitrogen) was added directly to the plate of cells during
the following morning (for a final concentration of 100 ng/ml). Cells were incu-
bated for 30 min at 37C (with 5% CO2). Cells were then trypsinized, treated
with hypotonic solution, and fixed. Metaphases were spread on microscope
slides, using standard G banding technique; the chromosomes were then
classified according to the International System for Human Cytogenetic
Nomenclature.
Growth Assay
For growth analysis, cells were plated on a 96-well plate. Cell growth was
determined by the number of viable cells in each well at different time points
by fixating the cells with 0.5% glutardialdehyde (Sigma-Aldrich) and staining
with methylene blue (Sigma-Aldrich) dissolved in 0.1M boric acid (pH 8.5).
Color extraction was performed using 0.1M hydrochloric acid. Color measure-
ment, proportional to the number of cells in each well, was determined using
the Synergy H1 Hybrid plate reader (BioTek Instruments) with absorbance
at 650 nM.
Induction of DSBs
DSBs were induced by adding phleomycin to the growth medium for a final
concentration of 20 ng/ml for 1 hr, followed by a wash and different recovery
times. Fixation and staining were as described above. Images were taken us-
ing a FV-1000 confocal microscope (Olympus) equipped with an IX81 inverted
microscope and a 40/0.6 objective and analyzed using NIH ImageJ software.
Cell-Cycle and Apoptosis Analyses
For cell-cycle analysis, cells were trypsinized and incubated in methanol
at20C for 2 hr or more. RNAdigestionwas performedwith 200 mg/ml RNase
A (Sigma-Aldrich) for half an hour at room temperature (RT). Cells were stained
with 50 mg/ml propidium iodide (PI) for 10min at 25C andwere taken for FACS
analysis. Stress induction for cell-cycle analysis was obtained by using phleo-
mycin at 20 mg/ml final concentration for 1 hr followed by 3 hr recovery in
fresh medium before fixation. For quantification of apoptosis, Annexin
V-FITC Apoptosis Detection Kit (eBioscience) was used, according to theCell Reports 16, 2499–2511, August 30, 2016 2509
manufacturer’s instructions. Acquisition was performed using FACSAria Cell
Sorting System (Becton Dickinson). Stress conditions for apoptosis were
induced using aphidicolin at a final concentration of 0.4 mM for 24 hr.
Statistical Analysis
Data are presented as means ± SEs. Significance of data was estimated by a
Student’s t test or by Mann-Whitney U test for distribution between popula-
tions. p < 0.05 was considered statistically significant.
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